ClinicalTrials.gg
Active, not recruitingNCT06605040ASTEROIDUpdated Apr 8, 2025

Scientific Content Disseminated Via Social Media for Physiotherapists

An interventional study of Dissemination via Social Media and Dissemination via Email in Physiotherapy, sponsored by Universidade Federal de Santa Maria. Active, not recruiting at 1 site in Brazil. Per ClinicalTrials.gov, last updated 2025-04-08.

Sponsored by Universidade Federal de Santa Maria · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Jun 2025, 1 year 5 months ago, but the record still lists the study as active, not recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Sex
All
01

Study summary

This study is designed to assess how effective social media is in disseminating scientific knowledge to physiotherapists in Brazil. The trial will include physiotherapists who treat at least three patients weekly and regularly use Instagram and WhatsApp. Participants will be randomly assigned to one of two groups: the experimental group will receive scientific content through Instagram, while the control group will receive the same content via email. Both groups will engage with the material for 10 weeks.

The scientific content covers seven key topics related to physiotherapy, such as musculoskeletal and sport rehabilitation, and will be tailored to clinical practice. For the Instagram group, content will be shared via posts, stories, and reels, while the email group will receive summaries and links to full articles. The study aims to evaluate the impact of these interventions on participants\' engagement with scientific content and its application to clinical practice.

Key outcomes will include the effectiveness of knowledge dissemination, participant feedback on the audiovisual content, and qualitative insights from interviews. The study will follow a specific timeline, with reassessment three months after the intervention to gauge long-term effects. Data will be analyzed using both quantitative and qualitative methods, ensuring a comprehensive understanding of the intervention\'s reach and feasibility.

Read the detailed description

This protocol details a randomized, single-blind controlled trial to assess how effectively scientific content can be disseminated to Brazilian physiotherapists using social media (Instagram). The study will follow physiotherapists who treat at least three patients per week and use Instagram and WhatsApp regularly. These participants will be randomized into two groups: an experimental group receiving content via Instagram and a control group receiving the same information via email.

The study will focus on seven areas relevant to physiotherapy practice, including musculoskeletal rehabilitation, cardiovascular care, and women's health. The content, developed using scientific articles, will be shared daily over 10 weeks. For the Instagram group, the content will be presented through various formats like posts, stories, and reels, with visually engaging elements to boost retention. The email group will receive daily summaries of the articles, similar to a journal-style format.

To maintain participant engagement, both groups will receive weekly summaries, and participants will be assessed on how well they apply the scientific content in practice. The primary outcomes include the effectiveness of content dissemination, participant engagement, and knowledge retention, evaluated through surveys, interviews, and technical assessments. Qualitative interviews will explore participants' experiences, and the quality of the audiovisual materials used will be rated by participants.

The trial will last for 10 weeks, followed by an additional week for reassessment and a three-month follow-up. Data will be analyzed quantitatively to measure the reach and effectiveness of the interventions, with feasibility analyzed using the RE-AIM framework. Qualitative data will be analyzed through thematic analysis, ensuring an in-depth understanding of the intervention's success. This study aims to offer insights into the best methods for delivering scientific knowledge to healthcare professionals via digital platforms.

02

Conditions studied

  • Physiotherapy

Keywords

  • Knowledge translation
  • continuous education
  • evidence-based practice
03

In context

Lead sponsor

Universidade Federal de Santa Maria is the lead sponsor of 37 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

  • Physiotherapists practicing in Brazil
  • Involvement in the rehabilitation of at least three patients per week
  • Having access to the social media platforms Instagram and WhatsApp at least once daily on most days of a typical week
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
120 participants (estimated)

Study arms

  • Experimental
    Social Media

    The group will receive scientific content via social media

    Other: Dissemination via Social Media

  • Active comparator
    Email

    The group will receive scientific content via email

    Other: Dissemination via Email

Interventions

  • OtherDissemination via Social Media

    Participants in the experimental group will follow a scientific Instagram profile where content will be shared. The profile will remain open, allowing permanent access to all posts. To optimize Instagram\'s algorithm, we will use an existing active profile. Any control group participants already following the profile will be removed upon allocation. For each selected article, we will create three presentations using Instagram features like carousel images and short videos, shared as posts, stories, and reels. This strategy will provide content for 30 weeks of daily posts. Each post will feature visually appealing graphics to convey scientific information and support evidence-based practice (EBP) competencies.

  • OtherDissemination via Email

    The participant allocated to the control group will receive a different summary each day, along with a link to the full article. This strategy was chosen to replicate the approach used by scientific journals to disseminate new issues.

06

What researchers measure

Primary outcomes

  1. Use of scientific information to make clinical decisions

    Participants should indicate their level using a scale 0-10 points (0 = I do not use; 10 = I only make clinical decisions using the best available evidence)

    Time frame: Baseline and the end of treatment at 10 weeks

  2. Understanding of scientific information interpretation for application in clinical practice

    Participants should indicate their level using a scale 0-10 points (0 = I do not understand; 10 = I have a complete understanding to apply scientific findings in clinical practice)

    Time frame: Baseline and the end of treatment at 10 weeks

  3. Motivation to search for scientific information that could support clinical decisions

    Participants should indicate their level using a scale 0-10 points (0 = I have no motivation; 10 = I am completely motivated)

    Time frame: Baseline and the end of treatment at 10 weeks

  4. Importance of scientific information in making clinical decisions

    Participants should indicate their level using a scale 0-10 points (0 = No importance; 10 = Extremely important)

    Time frame: Baseline and the end of treatment at 10 weeks

  5. Barriers to applying scientific findings

    Participants will describe their barriers to applying scientific findings in clinical practice and the number of barriers reported will be considered for analysis

    Time frame: Baseline and the end of treatment at 10 weeks

  6. Evidence-Based Practice Questionnaire (EBPQ)

    The EBPQ evaluates EBP competencies and has 24 items scored using a 7-point Likert scale (1-7 points); mean of the items will be used for analysis

    Time frame: Baseline and the end of treatment at 10 weeks

  7. Overcoming the reported barriers

    Participants will be asked whether the program helped to overcome the reported barriers (yes or no answer)

    Time frame: End of treatment at 10 weeks

Other outcomes

  1. Completion

    Number of participants who completed the study

    Time frame: End of treatment at 10 weeks

  2. Level of participation

    Participants should indicate their level using a scale 0-10 points (0 = I did not pay attention to any shared material; 10 = I read all the shared material of my interest)

    Time frame: End of treatment at 10 weeks

  3. Impact of program on the clinical practice and decisions

    Participants should indicate their level using a 5-point Likert scale (1=much worse, 2= worse, 3=the same, 4= better, 5=much better)

    Time frame: End of treatment at 10 weeks

  4. Use of shared information

    Participants will indicate whether they applied information shared during the program in clinical practice (yes or no answer)

    Time frame: End of treatment at 10 weeks

  5. Influence of the program

    Participants will indicate whether the program Influenced them to do something different in clinical practice (yes or no answer)

    Time frame: End of treatment at 10 weeks

  6. Intervention's modification

    We will register whether modifications to the interventions are necessary during the study

    Time frame: During the whole program which will take approximately 7 months

  7. Contamination of control group

    Checking if participant is following the Instagram's profile

    Time frame: During the 10 weeks of treatment

  8. Attitude towards seeking information from channels that facilitate the understanding of high-quality scientific findings

    Participants should indicate their level using a scale 0-10 points (0 = I will not use such information source; 10 = I will definitely use information source that facilitate my understanding)

    Time frame: End of treatment at 10 weeks

  9. Approach to study

    Participants will indicate whether the program influenced on the approach to studying technical content (yes or no answer)

    Time frame: End of treatment at 10 weeks

  10. Use of channels to facilitate understanding

    Participants will indicate whether they have used channels that facilitate the understanding of scientific findings

    Time frame: 3-month follow-up

  11. Application of information from different channels

    Participants will indicate whether they have applied information from channels that facilitate the understanding of scientific findings in clinical practice

    Time frame: 3-month follow-up

  12. Qualitative outcome

    Semi-structured interviews aimed at understanding their perceptions of the application of scientific content in clinical practice and their views on the interventions. Individual interviews will be conducted via telephone or video call, with responses to open-ended questions being audio-recorded.

    Time frame: End of treatment at 10 weeks

  13. Quality of information

    Participants should indicate their opinion about the quality of information using a scale 0-10 points (0 = terrible content; 10 = excellent content)

    Time frame: End of treatment at 10 weeks

  14. Visual quality of the shared materials

    Participants should indicate their opinion using a scale 0-10 points (0 = worst visual quality; 10 = excellent visual quality)

    Time frame: End of treatment at 10 weeks

  15. Metrics from social media

    We will collect engagement metrics from Instagram

    Time frame: During the whole program which will take approximately 7 months

07

Study locations

1 site
  • Federal University of Santa Maria
    Santa Maria, Rio Grande do Sul 97105-900, Brazil
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Nov 2024 (actual). Primary completion is estimated for Jun 2025, 7 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 15, 2024
First posted
Sep 20, 2024
StartActual
Nov 1, 2024
Primary completionEst.
Jun 2025
CompletionEst.
Aug 2025
Last update
Apr 8, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 8, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06605040
Lead sponsor
Universidade Federal de Santa Maria
Responsible party
Guilherme Nunes (Adjuct Professor, Universidade Federal de Santa Maria) — Principal investigator
First posted
Sep 20, 2024
Start date
Nov 1, 2024
Primary completion
Jun 2025 (estimated)
Completion
Aug 2025 (estimated)
Last update
Apr 8, 2025

Study contacts

Guilherme S Nunes, PhD
principal investigator · Universidade Federal de Santa Maria

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion